home / Australia / Genetic Technologies

Genetic Technologies Market Cap

$3.71 M

+1.08 M

GENE · April 23, 2025

Share price

$0.76

Enterprise Value

$0.11 B

Change (1-Year)

-66.0%

Global Rank

#9084

Country Rank

#136

Regions

Australia

Market cap

As of April 23, 2025, Genetic Technologies (GENE) has a market cap of $3.708 million USD. According to our data, Genetic Technologies is ranked No.9084 in global market value.

Sector Rank:

Biotech #805 Diagnostics and Testing #66

GENE Market Capitalization Growth

1 Years Growth:

-66.0%

3 Years Growth:

-91.2%

5 Years Growth:

-91.6%

10 Years Growth:

-99.2%

15 Years Growth:

-99.4%

20 Years Growth:

-99.8%

Total Growth:

-99%

Genetic Technologies Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Genetic Technologies Market Cap CAGR Chart

Genetic Technologies Market Cap History 2002 - 2025

Year	Market Cap	%Change
Apr 23, 2025	$3.71 M	-0.00%
Dec 31, 2024	$3.71 M	-68.13%
Dec 29, 2023	$11.63 M	-48.39%
Dec 30, 2022	$22.54 M	-50.53%
Dec 31, 2021	$45.56 M	-47.78%
Dec 31, 2020	$87.25 M	80.90%
Dec 31, 2019	$48.23 M	-8.98%
Dec 31, 2018	$52.99 M	-52.88%
Dec 29, 2017	$0.11 B	7.41%
Dec 30, 2016	$0.10 B	-59.70%
Dec 31, 2015	$0.26 B	39.18%
Dec 31, 2014	$0.19 B	-73.07%
Dec 31, 2013	$0.69 B	-34.40%
Dec 31, 2012	$1.06 B	-28.05%
Dec 30, 2011	$1.47 B	187.20%
Dec 31, 2010	$0.51 B	-8.26%
Dec 31, 2009	$0.56 B	9.52%
Dec 31, 2008	$0.51 B	-73.82%
Dec 31, 2007	$1.94 B	-49.62%
Dec 29, 2006	$3.86 B	-12.43%
Dec 30, 2005	$4.41 B	108.97%
Dec 31, 2004	$2.11 B	0.00%
Dec 31, 2003	$2.11 B	-26.89%
Dec 31, 2002	$2.88 B	100%

Similar Companies to Genetic Technologies

Name	Market Cap	Market cap difference	Regions
Myriad Genetics MYGN	$0.67 B	-0.000 M	USA
Natera NTRA	$20.08 B	0.001 M	USA
Illumina ILMN	$12.07 B	-0.000 M	USA
NeoGenomics NEO	$1.27 B	-0.000 M	USA
Exact Sciences EXAS	$8.19 B	-0.000 M	USA
Guardant Health GH	$5.63 B	0.000 M	USA
Fulgent Genetics FLGT	$0.58 B	0.000 M	USA
23andMe ME	$13.34 M	-9.345 M	USA
Veracyte VCYT	$2.45 B	0.000 M	USA
Bio-Rad Laboratories BIO	$6.92 B	1.207 B	USA
Pacific Biosciences PACB	$0.35 B	-0.000 M	USA
Personalis PSNL	$0.32 B	-0.000 M	USA
Twist Bioscience TWST	$2.24 B	-0.000 M	USA
Adaptive Biotechnologies ADPT	$1.10 B	-0.000 M	USA

About Genetic Technologies Inc.

Name

Genetic Technologies Ltd

Website

https://genetype.com

Headquarters

Prahran,VIC

symbol

GENE

CURRENCY

USD

country

Australia

fullTimeEmployees

exchange

NCM

firstTradeDateEpochUtc

1969/12/31

GENE Market Cap Formula

Market Cap	=	GENE Stock Price	*	GENE Shares Outstanding
	=	$0.76	*	4.85 M
	=	$3.71 M

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at hello@topmarketcap.net.

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe